Natural product-based therapy for Hypertension: The neem oil component Oleic acid inhibits pulmonary hypertension via down regulation of its target gene, 25/June/2014, 5.49 pm

Natural product-based treatment for Asthma: Hesperidin, a flavonoid enriched in citrus fruits, inhibits bronchial inflammation and asthma via down regulation of its target gene, 26/June/2014, 5.25 am
June 25, 2014
Mechanism of tumorigenesis: USP22 (ubiquitin-specific protease 22) increases the expression of immortality gene telomerase via up regulation of its target gene, 26/June/2014, 6.43 am
June 26, 2014
Show all

Prof. Chan SY,  Dr. Thomas B from the Divisions of Cardiovascular Medicine and Network Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA, has published a research paper in the 24 June 2014 J Clin Invest. (I.F: >15) stating that “Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension”  This study provides mechanistic insights into how miR-130/301 promotes PH pathogenesis.

In connection with this finding, Dr Boominathan, Founder Director-cum-chief scientist of GBMD, reports that: Natural product-based therapy for Hypertension: The neem oil component Oleic acid inhibits pulmonary hypertension via down regulation of its target gene This study suggests that pharmacological formulations encompassing “Oleic acid or its analogues” can be used in the treatment of pulmonary hypertension.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Natural product-based therapy for Hypertension: The neem oil component Oleic acid inhibits pulmonary hypertension via down regulation of its target gene, 25/June/2014, 5.50 pm,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.